NIH-funded research NIH-funded research

Understanding and Overcoming Barriers to Malaria Elimination in Asia-Pacific

Official title: Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region

Funded at Walter and Eliza Hall Inst Medical Res · NIH-11516991 · Data updated 2026-11-12

A multinational effort will test new ways to track and interrupt malaria transmission in countries like Cambodia and Papua New Guinea to help move toward elimination.

More Malaria research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWalter and Eliza Hall Inst Medical Res
NIH-funded
Lab location1 site (Parkville, AUSTRALIA)
Project startApril 1, 2025
Project endMarch 31, 2029
Funding year2026
Award (this year)$191,687
NIH project number3U19AI129392-11S1
Project IDNIH-11516991 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals living in the study areas who may be at risk for malaria, especially in settings with varying transmission intensity.

Less likely to help

Individuals outside the study sites or without malaria exposure are less likely to directly benefit.

What this research studies

This grant supports field, lab, and modeling work across several Asia-Pacific sites to improve how we monitor malaria, uncover why P. vivax keeps spreading, and test targeted interventions. Researchers will blend traditional disease surveillance with new surveys to identify where transmission hides and which tools work best in different settings. The project also explores how drug and insecticide resistance affect control efforts and how to allocate limited resources most effectively. Results could guide smarter, faster strategies for reducing malaria in diverse transmission environments.

Why it matters

Potential benefit: If successful, the program could streamline surveillance, optimize interventions, and hasten malaria elimination in the region, potentially reducing illness and saving lives.

How similar studies have gone: Past field studies and surveillance efforts have shown that integrated approaches can improve malaria control, though residual P. vivax remains challenging in some regions.

Where this research is happening

  • Walter and Eliza Hall Inst Medical Res
    Parkville, Australia
    Active

Researchers

  • Principal investigator: Mueller, Ivo J — Walter and Eliza Hall Inst Medical Res
  • Study coordinator: Mueller, Ivo J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.